Gene · 4973
Papers4,129
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 4,129
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Agri-Food Waste from Apple, Pear, and Sugar Beet as a Source of Protective Bioactive Molecules for Endothelial Dysfunction and Its Major Complications. | Antioxidants (Basel) | 2022 | 36139860 | PubTator, text mining | PubMed |
| Cell Surface Hsp90- and αMβ2 Integrin-Mediated Uptake of Bacterial Flagellins to Activate Inflammasomes by Human Macrophages. | Cells | 2022 | 36139453 | PubTator, text mining | PubMed |
| Identification Markers of Carotid Vulnerable Plaques: An Update. | Biomolecules | 2022 | 36139031 | PubTator, text mining | PubMed |
| Host-microbiome interactions regarding peri-implantitis and dental implant loss. | J Transl Med | 2022 | 36138430 | PubTator, text mining | PubMed |
| Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy. | Front Immunol | 2022 | 36131916 | PubTator, text mining | PubMed |
| DNA methylation as a pharmacodynamic marker of glucocorticoid response and glioma survival. | Nat Commun | 2022 | 36127421 | PubTator, text mining | PubMed |
| Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets. | Cancer Res | 2022 | 36126163 | PubTator, text mining | PubMed |
| Scavenger receptor-targeted plaque delivery of microRNA-coated nanoparticles for alleviating atherosclerosis. | Proc Natl Acad Sci U S A | 2022 | 36122215 | PubTator, text mining | PubMed |
| Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis. | Front Endocrinol (Lausanne) | 2022 | 36120471 | PubTator, text mining | PubMed |
| Discovering common pathogenetic processes between COVID-19 and sepsis by bioinformatics and system biology approach. | Front Immunol | 2022 | 36119022 | PubTator, text mining | PubMed |
| Pharmacotherapeutic potential of pomegranate in age-related neurological disorders. | Front Aging Neurosci | 2022 | 36118710 | PubTator, text mining | PubMed |
| VEGFA promotes the occurrence of PLA2R-associated idiopathic membranous nephropathy by angiogenesis via the PI3K/AKT signalling pathway. | BMC Nephrol | 2022 | 36114523 | PubTator, text mining | PubMed |
| Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening. | Cancer Epidemiol Biomarkers Prev | 2022 | 36112827 | PubTator, text mining | PubMed |
| Effects of curcumin on low-density lipoprotein oxidation: From experimental studies to clinical practice. | EXCLI J | 2022 | 36110563 | PubTator, text mining | PubMed |
| Hierarchical identification of a transcriptional panel for the histological diagnosis of lung neuroendocrine tumors. | Front Genet | 2022 | 36105102 | PubTator, text mining | PubMed |
| Distinct gene expression patterns for CD14++ and CD16++ monocytes in preeclampsia. | Sci Rep | 2022 | 36104441 | PubTator, text mining | PubMed |
| Hypertension and human immunodeficiency virus: A paradigm for epithelial sodium channels? | Front Cardiovasc Med | 2022 | 36093171 | PubTator, text mining | PubMed |
| Physical activity to reduce PCSK9 levels. | Front Cardiovasc Med | 2022 | 36093150 | PubTator, text mining | PubMed |
| Systemic consequences of abnormal cholesterol handling: Interdependent pathways of inflammation and dyslipidemia. | Front Immunol | 2022 | 36091062 | PubTator, text mining | PubMed |
| COVID-19 pandemic: A multidisciplinary perspective on the pathogenesis of a novel coronavirus from infection, immunity and pathological responses. | Front Immunol | 2022 | 36091053 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4973/papers?page=45